Sebela Pharmaceuticals: Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD
Braintree Laboratories, a part of Sebela Pharmaceuticals and a leading manufacturer of gastroenterology pharmaceutical products, announced positive topline results from two pivotal US phase 3 clinical trials
Read full article »
Sebela Pharmaceuticals develops and markets prescription products for gastroenterology, dermatology and women’s health.
Read more